Literature DB >> 23065222

Association of angiotensin-converting enzyme gene 2350 G/A polymorphism with diabetic retinopathy in Chinese Han population.

Shu Liang1, Min Pan, Nan Hu, Yu-Yu Wu, Hui Chen, Jian-Hua Zhu, Huai-Jin Guan, Ai-Min Sang.   

Abstract

The angiotensin-converting enzyme (ACE) gene is one of the most studied candidate genes related to diabetic retinopathy (DR). ACE 2350 G/A polymorphism (rs4343) is known among the polymorphisms of this gene to have the most significant effect on plasma ACE concentrations. The aim of the present study was to investigate the relationship between 2350 G/A polymorphism of ACE gene and the susceptibility of DR in Chinese Han population. A case-control study for 145 type 2 diabetes mellitus (DM) patients, including 63 type 2 DM without DR (NDR) and 82 type 2 DM with DR (DR), and 90 subjects of age, gender matched normal controls (NC group) was performed. ACE 2350 G/A genotypes were identified by polymerase chain reaction and restriction digestion in all study participants. The distribution of the ACE 2350 G/A genotypes (GG, GA, and AA) was 35.56, 45.55, and 18.89 % in the NC group, 28.57, 46.03, and 25.40 % in the NDR group, and 15.85, 46.34, and 37.81 % in the DR group, respectively. There were no significant differences in either genotype frequency distribution (P = 0.5266) or allele frequency distribution (P = 0.2425) between the NC group and NDR group. However, the distribution of genotype frequency (P = 0.0026) and allele frequency (P = 0.0003) in the DR group showed a significant difference when compared to that of NC group (P = 0.0075). Moreover, there was statistical difference in allele frequency distribution (P = 0.0328) between the DR group and the NDR group. No statistical differences were observed between ACE 2350 G/A polymorphism and the diabetes duration or types of DR. Results obtained in this study indicate that ACE 2350 G/A polymorphism is associated with DR in Han Chinese patients with type 2 DM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065222     DOI: 10.1007/s11033-012-2081-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  36 in total

1.  Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats.

Authors:  Yuan Zhu; Xiao-Ling Zhang; Bo-Feng Zhu; Yan-Ning Ding
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

Review 2.  Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.

Authors:  Henry H Q Heng; Steven W Bremer; Joshua B Stevens; Karen J Ye; Guo Liu; Christine J Ye
Journal:  J Cell Physiol       Date:  2009-09       Impact factor: 6.384

Review 3.  The role of genetics in susceptibility to diabetic retinopathy.

Authors:  Gerald Liew; Ronald Klein; Tien Y Wong
Journal:  Int Ophthalmol Clin       Date:  2009

4.  Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy.

Authors:  A Matsumoto; Y Iwashima; A Abiko; A Morikawa; M Sekiguchi; M Eto; I Makino
Journal:  Diabetes Res Clin Pract       Date:  2000-12       Impact factor: 5.602

5.  Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Authors:  N Chaturvedi; A K Sjolie; J M Stephenson; H Abrahamian; M Keipes; A Castellarin; Z Rogulja-Pepeonik; J H Fuller
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

7.  Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM.

Authors:  D K Nagi; M W Mansfield; M H Stickland; P J Grant
Journal:  Diabet Med       Date:  1995-11       Impact factor: 4.359

8.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.

Authors:  Jubao Duan; Mark S Wainwright; Josep M Comeron; Naruya Saitou; Alan R Sanders; Joel Gelernter; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

9.  Association of angiotensin-converting enzyme gene 2350G>A polymorphism with myocardial infarction in a Chinese population.

Authors:  Min-Hui Jiang; Mei-Fang Wei; Zhi-Hua Liu; Wen-Ping Jiang; Hai-Hua Geng; Zhi-Chu Cui; Dong-Lei Zhang; Jian-Hua Zhu
Journal:  Clin Appl Thromb Hemost       Date:  2008-04-28       Impact factor: 2.389

10.  The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  11 in total

Review 1.  Challenges in elucidating the genetics of diabetic retinopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Jerome I Rotter
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

2.  Interleukin-6 genotypes and serum levels in Chinese Hui population.

Authors:  Shu-Ping Gao; Shu Liang; Min Pan; Rong-Liang Sun; Chu Chen; Hong Luan; Min-Hui Jiang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 3.  Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World.

Authors:  Ashay D Bhatwadekar; Aumer Shughoury; Ameya Belamkar; Thomas A Ciulla
Journal:  Genes (Basel)       Date:  2021-07-31       Impact factor: 4.141

4.  Developments in Ocular Genetics: 2013 Annual Review.

Authors:  Inas F Aboobakar; R Rand Allingham
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2014 May-Jun

5.  Genetics in diabetic retinopathy: current concepts and new insights.

Authors:  Olga Simó-Servat; Cristina Hernández; Rafael Simó
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

Review 6.  Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics.

Authors:  Aniruddha Agarwal; Mohamed K Soliman; Yasir J Sepah; Diana V Do; Quan Dong Nguyen
Journal:  Pharmgenomics Pers Med       Date:  2014-12-12

Review 7.  Candidate gene studies of diabetic retinopathy in human.

Authors:  Petra Priščáková; Gabriel Minárik; Vanda Repiská
Journal:  Mol Biol Rep       Date:  2016-10-11       Impact factor: 2.316

8.  The genetics of retinopathy of prematurity: a model for neovascular retinal disease.

Authors:  Ryan Swan; Sang Jin Kim; J Peter Campbell; R V Paul Chan; Kemal Sonmez; Kent D Taylor; Xiaohui Li; Yii-Der Ida Chen; Jerome I Rotter; Charles Simmons; Michael F Chiang
Journal:  Ophthalmol Retina       Date:  2018-03-08

9.  Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension.

Authors:  Min-Hui Jiang; Ya-Min Su; Jian-Zhong Tang; Yan-Bo Shen; Xin-Tao Deng; Ding-Shan Yuan; Jie Wu; Min Pan; Zhong-Wei Huang
Journal:  Clinics (Sao Paulo)       Date:  2013-11       Impact factor: 2.365

Review 10.  Do Genomic Factors Play a Role in Diabetic Retinopathy?

Authors:  Andrea P Cabrera; Finny Monickaraj; Sampathkumar Rangasamy; Sam Hobbs; Paul McGuire; Arup Das
Journal:  J Clin Med       Date:  2020-01-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.